Comparison between Alkem Laboratories IPO and Healthcare Global IPO.
Alkem Laboratories IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Healthcare Global IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Alkem Laboratories IPO is up to ₹1,347.76 Cr whereas the issue size of the Healthcare Global IPO is up to ₹649.64 Cr. The final issue price of Alkem Laboratories IPO is ₹1,050.00 per share and of Healthcare Global IPO is ₹218.00 per share.
| Alkem Laboratories IPO | Healthcare Global IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,020.00 per share | ₹205.00 per share |
| Issue Price (Upper) | ₹1,050.00 per share | ₹218.00 per share |
| Issue Price (Final) | ₹1,050.00 per share | ₹218.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹100.00 per share | |
| Market Lot Size | 14 shares | 65 shares |
| Fresh Issue Size | 0 shares | 1,16,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹252.88 Cr |
| OFS Issue Size | 1,28,53,442 shares | 1,82,00,000 shares |
| OFS Issue Size (Amount) | up to ₹1,347.76 Cr | up to ₹396.76 Cr |
| Issue Size Total | 1,28,53,442 shares | 2,98,00,000 shares |
| Issue Size Total (Amount) | up to ₹1,347.76 Cr | up to ₹649.64 Cr |
Alkem Laboratories IPO opens on Dec 08, 2015, while Healthcare Global IPO opens on Mar 16, 2016. The closing date of Alkem Laboratories IPO and Healthcare Global IPO is Dec 10, 2015, and Mar 18, 2016, respectively.
| Alkem Laboratories IPO | Healthcare Global IPO | |
|---|---|---|
| Anchor Bid Date | Dec 07, 2015 | Mar 15, 2016 |
| Issue Open | Dec 08, 2015 | Mar 16, 2016 |
| Issue Close | Dec 10, 2015 | Mar 18, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Dec 23, 2015 | Mar 30, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Alkem Laboratories IPO P/E ratio is , as compared to Healthcare Global IPO P/E ratio of .
| Alkem Laboratories IPO | Healthcare Global IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 70.87 | |||||
| Promoter Shareholding (Post-Issue) | 66.23 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹12554.33 Cr. | ₹1854.66 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 15.4% |
In the Alkem Laboratories IPO Retail Individual Investors (RII) are offered 43,94,086 shares while in Healthcare Global IPO retail investors are offered 43,94,086 shares. Qualified Institutional Buyers (QIB) are offered 25,10,906 shares in Alkem Laboratories IPO and 89,40,000 shares in Healthcare Global IPO.
| Alkem Laboratories IPO | Healthcare Global IPO | |
|---|---|---|
| Anchor Investor Reservation | 37,66,358 shares | 1,34,10,000 shares |
| Market Maker Reservation | ||
| QIB | 25,10,906 shares | 89,40,000 shares |
| NII | 18,83,179 shares | 44,70,000 shares |
| RII | 43,94,086 shares | 29,80,000 shares |
| Employee | 2,98,913 shares | |
| Others | ||
| Total | 1,28,53,442 shares | 2,98,00,000 shares |
Alkem Laboratories IPO subscribed 44.29x in total, whereas Healthcare Global IPO subscribed 1.56x.
| Alkem Laboratories IPO | Healthcare Global IPO | |
|---|---|---|
| QIB (times) | 57.19x | 2.36x |
| NII (times) | 129.96x | 0.43x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.17x | 0.83x |
| Employee (times) | 0.67x | |
| Other (times) | ||
| Total (times) | 44.29x | 1.56x |
